Send and receive information on adverse drug reactions (ADRs)
Information
Type
Guidance
Regulated products
Medical Devices
Topics
Health And Social Care
Published
December 18, 2014
Last updated
May 9, 2024
Description
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Tags
Organization
Country / Region
United Kingdom
License
Open Government Licence 2.0 (United Kingdom)